retatrutide triple agonist glp-1 gip glucagon phase 2 results is a novel peptide at the receptor, receptor, and receptor. 22-24% weight loss at 48 weeks with a similar tolerability profile to #tirzepatide. @LillyPad #medtwitter #endotwitter retatrutide triple agonist glp-1 gip
Pay in 4 interest-free payments of $6.73 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5



















:max_bytes(150000):strip_icc()/information-about-kreteks-and-clove-cigarettes-2825286-5c097c0dc9e77c00014bf2e1.png)


